BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24631520)

  • 21. Diosmetin Induces Apoptosis of Acute Myeloid Leukemia Cells.
    Roma A; Rota SG; Spagnuolo PA
    Mol Pharm; 2018 Mar; 15(3):1353-1360. PubMed ID: 29412683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia.
    Tailler M; Senovilla L; Lainey E; Thépot S; Métivier D; Sébert M; Baud V; Billot K; Fenaux P; Galluzzi L; Boehrer S; Kroemer G; Kepp O
    Oncogene; 2012 Jul; 31(30):3536-46. PubMed ID: 22105358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AEE788 is a vascular endothelial growth factor receptor tyrosine kinase inhibitor with antiproliferative and proapoptotic effects in acute myeloid leukemia.
    Barbarroja N; Torres LA; Rodriguez-Ariza A; Valverde-Estepa A; Lopez-Sanchez LM; Ruiz-Limon P; Perez-Sanchez C; Carretero RM; Velasco F; López-Pedrera C
    Exp Hematol; 2010 Aug; 38(8):641-52. PubMed ID: 20380868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxyurea synergizes with valproic acid in wild-type p53 acute myeloid leukaemia.
    Leitch C; Osdal T; Andresen V; Molland M; Kristiansen S; Nguyen XN; Bruserud Ø; Gjertsen BT; McCormack E
    Oncotarget; 2016 Feb; 7(7):8105-18. PubMed ID: 26812881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Natural Combination Extract of Viscum album L. Containing Both Triterpene Acids and Lectins Is Highly Effective against AML In Vivo.
    Delebinski CI; Twardziok M; Kleinsimon S; Hoff F; Mulsow K; Rolff J; Jäger S; Eggert A; Seifert G
    PLoS One; 2015; 10(8):e0133892. PubMed ID: 26244918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CS2164 suppresses acute myeloid leukemia cell growth via inhibiting VEGFR2 signaling in preclinical models.
    Deng M; Zhao H; Chen Q; Zhao J; Shi Y; Yu L; Fang Z; Xu B
    Eur J Pharmacol; 2019 Jun; 853():193-200. PubMed ID: 30928630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1.
    Chaib H; Nebbioso A; Prebet T; Castellano R; Garbit S; Restouin A; Vey N; Altucci L; Collette Y
    Leukemia; 2012 Apr; 26(4):662-74. PubMed ID: 21979880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-selective cytotoxic Ca2+ overload in acute myeloid leukemia cells and attenuation of disease progression in mice by synergistically acting polyphenols curcumin and carnosic acid.
    Pesakhov S; Nachliely M; Barvish Z; Aqaqe N; Schwartzman B; Voronov E; Sharoni Y; Studzinski GP; Fishman D; Danilenko M
    Oncotarget; 2016 May; 7(22):31847-61. PubMed ID: 26870993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct inhibition of human acute myeloid leukemia cell growth by IL-12.
    Ferretti E; Di Carlo E; Cocco C; Ribatti D; Sorrentino C; Ognio E; Montagna D; Pistoia V; Airoldi I
    Immunol Lett; 2010 Oct; 133(2):99-105. PubMed ID: 20705102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia.
    Eriksson A; Höglund M; Lindhagen E; Aleskog A; Hassan SB; Ekholm C; Fhölenhag K; Jensen AJ; Löthgren A; Scobie M; Larsson R; Parrow V
    Biochem Pharmacol; 2010 Nov; 80(10):1507-16. PubMed ID: 20705060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen.
    Yip KW; Mao X; Au PY; Hedley DW; Chow S; Dalili S; Mocanu JD; Bastianutto C; Schimmer A; Liu FF
    Clin Cancer Res; 2006 Sep; 12(18):5557-69. PubMed ID: 17000693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor Effect of the Atypical Retinoid ST1926 in Acute Myeloid Leukemia and Nanoparticle Formulation Prolongs Lifespan and Reduces Tumor Burden of Xenograft Mice.
    El-Houjeiri L; Saad W; Hayar B; Aouad P; Tawil N; Abdel-Samad R; Hleihel R; Hamie M; Mancinelli A; Pisano C; El Hajj H; Darwiche N
    Mol Cancer Ther; 2017 Oct; 16(10):2047-2057. PubMed ID: 28619754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. β-Catenin and AKT are promising targets for combination therapy in acute myeloid leukemia.
    Wang L; You LS; Ni WM; Ma QL; Tong Y; Mao LP; Qian JJ; Jin J
    Leuk Res; 2013 Oct; 37(10):1329-40. PubMed ID: 23867056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of FGFR1beta signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells.
    Karajannis MA; Vincent L; Direnzo R; Shmelkov SV; Zhang F; Feldman EJ; Bohlen P; Zhu Z; Sun H; Kussie P; Rafii S
    Leukemia; 2006 Jun; 20(6):979-86. PubMed ID: 16598308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia.
    Barghout SH; Patel PS; Wang X; Xu GW; Kavanagh S; Halgas O; Zarabi SF; Gronda M; Hurren R; Jeyaraju DV; MacLean N; Brennan S; Hyer ML; Berger A; Traore T; Milhollen M; Smith AC; Minden MD; Pai EF; Hakem R; Schimmer AD
    Leukemia; 2019 Jan; 33(1):37-51. PubMed ID: 29884901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective targeting of NAMPT by KPT-9274 in acute myeloid leukemia.
    Mitchell SR; Larkin K; Grieselhuber NR; Lai TH; Cannon M; Orwick S; Sharma P; Asemelash Y; Zhang P; Goettl VM; Beaver L; Mims A; Puduvalli VK; Blachly JS; Lehman A; Harrington B; Henderson S; Breitbach JT; Williams KE; Dong S; Baloglu E; Senapedis W; Kirschner K; Sampath D; Lapalombella R; Byrd JC
    Blood Adv; 2019 Feb; 3(3):242-255. PubMed ID: 30692102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hispolon induces apoptosis through JNK1/2-mediated activation of a caspase-8, -9, and -3-dependent pathway in acute myeloid leukemia (AML) cells and inhibits AML xenograft tumor growth in vivo.
    Hsiao PC; Hsieh YH; Chow JM; Yang SF; Hsiao M; Hua KT; Lin CH; Chen HY; Chien MH
    J Agric Food Chem; 2013 Oct; 61(42):10063-73. PubMed ID: 24093560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combination of phenylbutyrate and 5-Aza-2'deoxycytidine inhibits human Kasumi-1 xenograft tumor growth in nude mice].
    Hao CL; Lin D; Wang LH; Xing HY; Wang M; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):658-61. PubMed ID: 15634569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium caseinate induces increased survival in leukaemic mouse J774 model.
    Córdova-Galaviz Y; Ledesma-Martínez E; Aguíñiga-Sánchez I; Soldevila-Melgarejo G; Soto-Cruz I; Weiss-Steider B; Santiago-Osorio E
    In Vivo; 2014; 28(5):819-25. PubMed ID: 25189894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.